Investigation of inflammatory activity in ulcerative colitis

Romanian Journal of Morphology and Embryology

Volumn 55, Issue 4, 2014, Pages 1345-1351

  Boldeanu, Mihai Virgil ^a   Siloşi, Isabela ^a   Ghiluşi, Mirela ^b   Cojocaru, Manole ^c   Biciuşcă, Viorel ^a   Avrămescu, Carmen Silvia ^a   Cojocaru, Inimioara Mihaela ^d   Ciurea, Tudorel ^a   Albu, Dinu Florin ^d   Siloşi, Cristian Adrian ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Emergency County Hospital   (Romania)

^c TITU MAIORESCU UNIVERSITY   (Romania)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Inflammation; Interleukin 13; Interlukin 17; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 13; INTERLEUKIN 17;

ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; INFLAMMATION; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; INTESTINAL MUCOSA; MALE;

EID: 84920383344     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ponder A, Long MD, A clinical review of recent findings in the epidemiology of inflammatory bowel disease, Clin Epidemiol, 2013, 5:237-247.
2. Geboes K, Crohn’s disease, ulcerative colitis or indeterminate colitis-how important is it to differentiate? Acta Gastroenterol Belg, 2001, 64(2):197-200.
3. Sartor RB, Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis, Nat Clin Pract Gastroenterol Hepatol, 2006, 3(7):390-407.
4. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology, Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 2010, 105(3):501-523; quiz 524.
5. Juckett G, Trivedi R, Evaluation of chronic diarrhea, Am Fam Physician, 2011, 84(10):1119-1126.
6. Rönnblom A, Samuelsson SM, Ekbom A, Ulcerative colitis in the county of Uppsala 1945-2007: incidence and clinical characteristics, J Crohns Colitis, 2010, 4(5):532-536.
7. Jantchou P, Monnet E, Carbonnel F, Environmental risk factors in Crohn’s disease and ulcerative colitis (excluding tobacco and appendicectomy), Gastroenterol Clin Biol, 2006, 30(6-7):859-867.
8. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, Theodossi A, Williams GT, Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflame matory bowel disease. The British Society of Gastroenterology Initiative, J Clin Pathol, 1997, 50(2):93-105.
9. Truelove SC, Witts LJ, Cortisone in ulcerative colitis; preliminary report on a therapeutic trial, Br Med J, 1954, 2(4884): 375-378.
10. Buckell NA, Lennard-Jones JE, Hernandez MA, Kohn J, Riches PG, Wadsworth J, Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management, Gut, 1979, 20(1):22-27.
11. Danese S, Fiocchi C, Ulcerative colitis, N Engl J Med, 2011, 365(18):1713-1725.
12. Xu XR, Liu CQ, Feng BS, Liu ZJ, Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease, World J Gastroenterol, 2014, 20(12):3255-3264.
13. Meijer MJW, Mieremet-Ooms MA, van der Zon AM, van Duijn W, van Hogezand RA, Sier CF, Hommes DW, Lamers CB, Verspaget HW, Increased mucosal matrix metalloproteinase-1,-2,-3 and-9 activity in patients with inflammatory bowel disease and the relation with Crohn’s disease phenotype, Dig Liver Dis, 2007, 39(8):733-739.
14. Li J, Tian H, Jiang HJ, Han B, Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis, World J Gastroenterol, 2014, 20(42):15899-15909.
15. Mohammadi M, Zahedi MJ, Nikpoor AR, Baneshi MR, Hayatbakhsh MM, Interleukin-17 serum levels and TLR4 polymorphisms in ulcerative colitis, Iran J Immunol, 2013, 10(2):83-92.
16. Hundorfean G, Neurath MF, Mudter J, Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease, Inflamm Bowel Dis, 2012, 18(1): 180-186.
17. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD, Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution, Gastroenterology, 2005, 129(2):550-564.
18. Vermeire S, Van Assche G, Rutgeerts P, Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut, 2006, 55(3): 426-431.
19. Geboes K, Riddell R, Öst A, Jensfelt B, Persson T, Löfberg R, A reproducible grading scale for histological assessment of inflammation in ulcerative colitis, Gut, 2000, 47(3):404-409.
20. DeRoche TC, Xiao SY, Liu X, Histological evaluation in ulcerative colitis, Gastroenterol Rep (Oxf), 2014, 2(3):178-192.
21. Bryant RV, Winer S, Spl T, Riddell RH, Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative, J Crohns Colitis, 2014, 8(12):1582-1597.
22. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R; European Society of Pathology (ESP); European Crohn’s and Colitis Organisation (ECCO), European consensus on the histopathology of inflammatory bowel disease, J Crohns Colitis, 2013, 7(10):827-851.
23. Langner C, Magro F, Driessen A, Ensari A, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, Geboes K; European Society of Pathology; European Crohn’s and Colitis Foundation, The histopathological approach to inflammatory bowel disease: a practice guide, Virchows Arch, 2014, 464(5):511-527.
24. Surawicz CM, Haggitt RC, Husseman M, McFarland LV, Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterology, 1994, 107(3):755-763.
25. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T, Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study, Gastroenterology, 2007, 133(4):1099-1105; quiz 1340-1341.